These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2995082)

  • 1. Effects of GABA receptor agonists on [3H]dopamine release from median eminence and pituitary neurointermediate lobe.
    Anderson R; Mitchell R
    Eur J Pharmacol; 1985 Sep; 115(1):109-12. PubMed ID: 2995082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for GABAB autoreceptors in median eminence.
    Anderson RA; Mitchell R
    Eur J Pharmacol; 1985 Dec; 118(3):355-8. PubMed ID: 3002813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAA and GABAB receptor-mediated inhibition of release of 5-hydroxytryptamine in the intermediate lobe of the rat pituitary gland.
    Racké K; Holzbauer M; Sharman DF; Cooper TR
    Neuroscience; 1987 Nov; 23(2):679-84. PubMed ID: 2830560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and autoreceptor-controlled release of [3H]-GABA by the hypothalamic median eminence and pituitary neurointermediate lobe.
    Anderson R; Mitchell R
    Neuroendocrinology; 1986; 42(4):277-84. PubMed ID: 3960272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on [3H]GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type.
    Pittaluga A; Asaro D; Pellegrini G; Raiteri M
    Eur J Pharmacol; 1987 Nov; 144(1):45-52. PubMed ID: 2830119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.
    Schneider D; Schlicker E; Malinowska B; Molderings G
    Br J Pharmacol; 1991 Oct; 104(2):478-82. PubMed ID: 1665738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study.
    Xi ZX; Stein EA
    Brain Res; 1998 Jul; 798(1-2):156-65. PubMed ID: 9666112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid release of [3H]dopamine from median eminence and striatal synaptosomes.
    Gregerson KA; Selmanoff M
    J Neurochem; 1987 Apr; 48(4):1222-30. PubMed ID: 3819726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of 3H-dopamine release by presynaptic GABA and glutamate heteroreceptors in the synaptosomes of the rat nucleus accumbens].
    Kovalev GI; Hetey L
    Biull Eksp Biol Med; 1987 Jan; 103(1):75-8. PubMed ID: 3026521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic modulation of the release of GABA by GABAA receptors in pars compacta and by GABAB receptors in pars reticulata of the rat substantia nigra.
    Floran B; Silva I; Nava C; Aceves J
    Eur J Pharmacol; 1988 Jun; 150(3):277-86. PubMed ID: 2843383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAA receptor-mediated inhibition of N-methyl-D-aspartate-evoked [3H]dopamine release from mesencephalic cell cultures.
    Chaudieu I; St-Pierre JA; Quirion R; Boksa P
    Eur J Pharmacol; 1994 Nov; 264(3):361-9. PubMed ID: 7698177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different gamma-aminobutyric acid receptor subtypes are involved in the regulation of opiate-dependent and independent luteinizing hormone-releasing hormone secretion.
    Masotto C; Wisniewski G; Negro-Vilar A
    Endocrinology; 1989 Jul; 125(1):548-53. PubMed ID: 2544412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric GABA-containing nerves projecting to the guinea-pig inferior mesenteric ganglion modulate acetylcholine release.
    Parkman HP; Stapelfeldt WH; Williams CL; Lennon VA; Szurszewski JH
    J Physiol; 1993 Nov; 471():191-207. PubMed ID: 8120803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical antagonism by bicuculline of the inhibition by baclofen of the electrically evoked release of [3H]GABA from rat cerebral cortex slices.
    Maurin Y
    Eur J Pharmacol; 1988 Oct; 155(3):219-27. PubMed ID: 2853062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of tuberoinfundibular dopaminergic function resulting from chronic hyperprolactinemia in rats.
    Sarkar DK; Gottschall PE; Meites J
    Endocrinology; 1984 Oct; 115(4):1269-74. PubMed ID: 6479093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin.
    Székács D; Bodnár I; Mravec B; Kvetnansky R; Vizi ES; Nagy GM; Fekete MI
    Neurochem Int; 2007 Jan; 50(2):427-34. PubMed ID: 17141375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of gamma-aminobutyric acid receptors in the neurointermediate lobe of the amphibian Xenopus laevis.
    Verburg-van Kemenade BM; Jenks BG; Lenssen FJ; Vaudry H
    Endocrinology; 1987 Feb; 120(2):622-8. PubMed ID: 3026779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic effect of GABAA receptor agonists on prolactin secretion: evidence for two types of GABAA receptor complex on lactotrophes.
    Anderson R; Mitchell R
    Eur J Pharmacol; 1986 May; 124(1-2):1-9. PubMed ID: 3013656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of gamma-aminobutyric acid-receptors of the B-subtype inhibits the dopamine-induced enhancement of the release of cholecystokinin-like immunoreactivity from slices of rat dorsal caudatoputamen.
    Conzelmann U; Meyer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):541-6. PubMed ID: 3039381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between excitatory and inhibitory amino acids in the regulation of luteinizing hormone-releasing hormone secretion.
    Donoso AO; López FJ; Negro-Vilar A
    Endocrinology; 1992 Sep; 131(3):1559-61. PubMed ID: 1354606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.